Nicotine abuse vaccine - Independent PharmaceuticaAlternative Names: Niccine
Latest Information Update: 16 Jul 2016
At a glance
- Originator Independent Pharmaceutica
- Class Drug withdrawal therapies; Smoking cessation therapies; Vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Smoking-withdrawal in Sweden (IM, Injection)
- 11 Apr 2008 Phase-I clinical trials in Smoking withdrawal in Sweden (IM)